Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride-bicarbonate exchangers are integral membrane proteins that facilitate the electroneutral exchange of chloride ions (Cl⁻) and bicarbonate ions (HCO₃⁻) across plasma membranes. These exchangers are crucial for maintaining acid-base balance, regulating cellular and systemic pH, disposing of metabolic CO₂ waste, and controlling fluid movement in tissues. Key isoforms include Band 3 (AE1/SLC4A1), AE2 (SLC4A2), and AE3 (SLC4A3), each with distinct tissue distributions and physiological roles. Mutations in these exchangers can lead to disorders such as hereditary spherocytosis and distal renal tubular acidosis.
Inhibition of Cl⁻/HCO₃⁻ exchange
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride-Bicarbonate Exchanger (AE).